8 полученные результаты
This application is a 371 application of PCT/US2003/041448 filed Dec. 24, 2003.
1. FIELD OF THE INVENTION
The invention encompasses ketone compounds and pharmaceutically acceptable salts, hydrates, solvates, and mixtures thereof; compositions comprising urea and thiourea compounds and
1. FIELD OF THE INVENTION
The invention encompasses ketone compounds and pharmaceutically acceptable salts, hydrates, solvates, and mixtures thereof; compositions comprising urea and thiourea compounds and pharmaceutically acceptable salts, hydrates, solvates, and mixtures thereof; and methods for
1. FIELD OF THE INVENTION
The invention encompasses ketone compounds and pharmaceutically acceptable salts, hydrates, solvates, and mixtures thereof; compositions comprising urea and thiourea compounds and pharmaceutically acceptable salts, hydrates, solvates, and mixtures thereof; and methods for
1. FIELD OF THE INVENTION
The invention encompasses ketone compounds and pharmaceutically acceptable salts, hydrates, solvates, and mixtures thereof; compositions comprising urea and thiourea compounds and pharmaceutically acceptable salts, hydrates, solvates, and mixtures thereof; and methods for
1. FIELD OF THE INVENTION
The invention encompasses ketone compounds and pharmaceutically acceptable salts, hydrates, solvates, and mixtures thereof; compositions comprising urea and thiourea compounds and pharmaceutically acceptable salts, hydrates, solvates, and mixtures thereof and methods for
1. FIELD OF THE INVENTION
The present invention relates to ketone compounds; compositions comprising the ketone compounds; and methods for treating or preventing a disease or disorder, such as cardiovascular disease, dyslipidemia, dyslipoproteinemia, a disorder of glucose metabolism, Alzheimer's
The present invention relates to novel oligomeric compounds which have utility as Nutraceutical and/or medicaments for producing ketosis in humans and animals for nutraceutical or therapeutic purposes.
It is known that ketone bodies, particularly (R)-3-hydroxybutyrate (D-.beta.-hydrotybutyrate) and
BACKGROUND
There is an overwhelming obesity problem in the United States of America and around the globe. This problem is caused mainly by lack of energy expenditure from the human body. Energy expenditure in the form of exercise (mobility) and environmental adaptation has shifted dramatically in